database has been questioned because a considerable portion of the archived information does not truly reflect polymorphism, but simply represents sequencing errors; SNPs in the database are often defined as sequence differences in clusters of overlapping expressed sequence tags, or differences among large-insert clones such as bacterial artificial chromosomes assembled by computer algorithms (Altshuler et al. 2000; Sachidanandam et al. 2001; Venter et al. 2001) . Moreover, elements deposited in the dbSNP database are not, for the most part, located within genomic regions that contain genes. Although extragenetic SNPs can serve as markers to identify loci for susceptibility to common diseases or loci defining drug sensitivity, they might not be appropriate for such studies if the goal is ultimately to identify the genes involved.
There are two approaches to construction of SNP databases; one is genome-wide screening, and the other is genebased screening. The former, the "whole-genome shotgun method," involves sequencing of genomic clones prepared from a number of individuals; this approach does not require synthesis of oligonucleotide primers for polymerase chain reaction (PCR) amplification or knowledge of genomic sequence (Altshuler et al. 2000; Sachidanandam et al. 2001; Venter et al. 2001) . However, to avoid spurious SNPs, the quality of results depends heavily on the accuracy of detection algorithms; such accuracy is technically difficult to achieve, and, furthermore, most SNPs identified in this way inevitably will be located in intergenic regions. The second method is based on locus-specific PCR amplification and direct sequencing of the products, but it requires millions of oligonucleotide primers and extensive genomic sequence information to cover the whole genome. However, the latter approach can focus on specific regions of interest to explore for variations, i.e., promoter regions or coding elements. Because gene-based variations should have greater usefulness for identifying loci containing genes of medical or biological importance by means of association studies, we have adopted this strategy and describe here a large-scale discovery of genetic variations within genecontaining regions as one of the Japanese Millennium Genome projects.
Introduction
During the past several years, knowledge of the human genomic sequence has accumulated to the point that millions of single-nucleotide polymorphisms (SNPs) are now registered in publically available databases such as dbSNP (Sherry et al. 2001) . However, the quality of the dbSNP
Subjects and methods

Selection of gene-containing regions
Because we decided to concentrate on finding SNPs present in genes or their promoters, we defined "gene regions" by four approaches. First, we extracted appropriate genomic sequences from the GenBank DNA database (Benson et al. 2002) by selecting entries containing annotations of exons and promoters. Second, we applied an exon-prediction program (GENSCAN; Burge and Karlin 1997) and searched for homologies using BLAST ver.2 (Altschul et al. 1997) , partly with sim4 (Florea et al. 1998) , between mRNA/ cDNA/Unigene records and genomic sequence records. Third, we determined exonic elements by comparing mRNA records with the genomic contig records in the NCBI Reference Sequence Project (RefSeq; Pruitt and Maglott 2001) using our original computer software. Last, we defined promoter regions as encompassing 2.5 kb of DNA upstream of the first exon. To avoid identifying controversial SNPs in repetitive elements, we eliminated such regions by means of the RepeatMasker program (http://ftp.genome.washington.edu/RM/RepeatMasker. html), using the option of "Do not mask simple repeats and low-complexity DNA," and we did not amplify regions in which more than 20% of the DNA was repetitive. PCR primers were selected to amplify extracted exons, introns, and promoter regions using the computer program Primer 3.0 (Rozen and Skaletsky 2000) ; the size of each PCR product was designed to be approximately 0.6 or 1.2 kb. Internal and nested primers were also selected for sequencing when necessary.
DNA samples
After obtaining written informed consent, genomic DNA was extracted from the peripheral blood of 24 unrelated female Japanese volunteers. At first we had included samples from male volunteers as well; however, pseudoautosomal regions can confound assignment of variations to sex chromosomes, and we decided not to investigate the Y chromosome further. No identifying or phenotypic information was recorded in relation to any specimen, so that links to individual donors were irreversibly broken. The Ethics Committee at the Institute of Medical Science, University of Tokyo had given us permission to analyze these samples.
Locus-specific PCR amplification and direct sequencing of PCR products
In the interest of cost-effectiveness, we mixed equal amounts of DNA from three unrelated individuals because preliminary data had indicated that one variant in six chromosomes could be effectively detected in this way Yamada et al. 2000) . Each PCR experiment was performed with 20 ng of pooled genomic DNA. Amplification was carried out under the conditions described in our web site (http://snp.ims.u-tokyo.ac.jp), and for liquid handling we used Biomek2000 (Beckman Coulter, Fullerton, CA, USA) and Multimek96 (Beckman Coulter) robotics. PCR products were purified on Multiscreen384-PCR plates (Millipore, Bedford, MA, USA) according to the manufacturer's instructions. The purified products were sequenced directly, with sets of two PCR primers for both strands. When the target size of a PCR product was 1.2 kb, two internal primers were also used to cover the whole amplified region with both strands. In case a PCR product showed faint nonspecific band(s) after electrophoresis on an agarose gel, two nested primers rather than the PCR primers themselves were used for sequencing. Samples were sequenced using Big-Dye terminator chemistry on ABI 3700 capillary sequencers (Applied Biosystems, Foster City, CA, USA). To perform large-scale sequencing, we introduced 22 capillary sequencers. All procedures were administered by means of bar-code systems to avoid human errors.
SNP detection
The Polyphred Computer program (Nickerson et al. 1997 ) was used to assemble fragments and indicate candidate SNPs. For verification we inspected most of the amplified regions and all candidate SNPs visually. When all eight of the pooled samples showed the same allelic ratio on an electropherogram, we did not consider the candidate site to be a polymorphism, because noise and/or the presence of homologous regions can present risks of false verification.
SNP database
Our database was constructed as described previously (Hirakawa et al. 2002) . For statistical purposes, exons and genomic regions were defined as sequences in the RefSeq (build 29) whose accession format began with XM or NM, or with NT, respectively.
Results and discussion
We designed PCR primers for 260 448 gene-containing fragments from throughout the human genome, and we were able to analyze 84% of them for polymorphisms. The unsuccessful PCR amplifications may have been due to errors in the reference sequences in the genomic databases.
We screened 153 774 997 nonredundant nucleotides, this number corresponding to approximately 5% of the human genome, and identified 190 562 genetic variations; 174 269 were SNPs and 16 293 were insertion/deletion polymorphisms, including 2439 repeat-length polymorphisms such as microsatellites (Table 1) . Approximately 70% of the SNPs were transitions, this type occurring 2.3 times more often than transversions, an observation consistent with previous results and theory Dawson et al. 2001; Venter et al. 2001) . Interestingly, the number of insertion/deletion polymorphisms decreased exponentially according to their sizes (Fig. 1) . Because our screening method should not affect the discovery rate regardless of the sizes of insertion/deletions, this result probably reflects a genome-wide distribution of this kind of polymorphism.
The distribution of polymorphisms with respect to genetic structures is summarized in Table 2 . Approximately 3% of the SNPs we identified were mapped to multiple genomic regions, mainly as a consequence of redundancy in the RefSeq (build 29) database. However, 10% of our SNPs could not be mapped to any of the sequences deposited in databases, even though we had synthesized the PCR primers using GenBank data. We think it is clear that the RefSeq database is far from complete, because draft sequences still cover 35% of its genomic contigs. Table 2 will surely be in need of modification whenever this database is changed to reflect new data.
Among 12 830 biallelic SNPs identified within regions judged to contain coding elements on the basis of annota- (Table 3) . When we classified these SNPs further on the basis of the positions of variant bases within codons, half were located at the third nucleotide (Table 4) , supporting the theory that many deleterious alleles encoding nonsynonymous substitutions at the first or second site probably have been eliminated during human evolution.
The calculated length of all exonic sequences analyzed in this study was 27 015 998 nucleotides. Because by our estimates the combined length of all exons in the human genome is 67 214 630 nucleotides, the exons we screened for genetic variations corresponded to approximately 40% of the entire exonic sequence of the genome. The estimate of 67.2 Mb is consistent with previous estimates that were based on average exon length and the number of genes in the genome (Sachidanandam et al. 2001; Venter et al. 2001) . We went on to investigate the coverage of our data set against known genes. When we used the set of 46 118 XM or NM accession formats (RefSeq build 29) as known genes, 48% (22 155) were found to contain one or more of the SNPs identified by this study. Furthermore, as summarized in Table 5 , the density of our SNPs in autosomes appeared to range from 6.6 to 34.4 kb. We conclude that our SNP collection should be useful for genome-wide case control association studies, especially when those studies focus on regions containing specific genes.
We also determined allelic frequencies for 78 570 of the SNPs identified in our study using our own high-throughput genotyping method (Ohnishi et al. 2001) . The distribution of allelic frequencies was largely even, with an average minor-allelic frequency of 24% (Fig. 2 and http://snp.ims. u-tokyo.ac.jp). These frequency data will serve as controls when case-control association studies are performed in the Japanese population.
We found, on average, one polymorphism in every 807 bp, a lower density than that found in other studies, where a variation was reported to occur approximately every 300 bp (Cargill et al. 1999; Halushka et al. 1999; Stephens et al. 2001 ). In the traditional definition of genetics, to be called a polymorphism, a variation at a given site SNPs, Single-nucleotide polymorphisms must be present in at least 1% of the population; therefore, an assumption of classical neutral theory of population genetics would suggest that polymorphisms are present at 11 million sites in the human genome (Kruglyak and Nickerson 2001) . Under that criterion, a variation should be found every 272 bp, but our two pilot studies Yamada et al. 2000) identified one gene-based SNP in every 641 and 638 bp, respectively. A reason for this discrepancy might be ethnic difference; the Japanese population seems more homogeneous than others. Other discrepancies may be related to study designs, particularly in regard to sizes of the population samples and whether individual DNA samples are mixed. Three previous studies analyzed more than 50 individuals each, among whom a considerable percentage of the SNPs identified had low minor-allelic frequencies: Halushka et al. (1999) identified SNPs with an average minor-allelic frequency of 11%, Cargill et al. (1999) reported that about 70% of the SNPs they identified had minor-allelic frequencies of Ͻ15%, and Stephens et al. (2001) observed 38% of their SNPs only once, in single heterozygotes. Because we analyzed only 24 individuals and mixed three DNAs in one tube (i.e., eight analytes), it is possible that we did not detect variations having low minor-allelic frequencies, as Fig. 2 indicates. However, we do not think this will diminish the value of our database, because we consider that SNPs with low frequencies of minor alleles are not necessary at present. Detecting significant association of any SNP with a minor-allelic frequency of Ͻ5% with common diseases through a genomewide approach would require a sample size of up to 10 000 people. It is simply not practical for such a large group to be genotyped for 100 000 SNP loci within a reasonable period of time using systems that are available at present. All of our data and our methods, including primer sequences and PCR conditions, are freely available from our web site (http://snp.ims.u-tokyo.ac.jp). We believe that this information constitutes a potent infrastructure for the next step toward personalized medicine, i.e., whole-genome association studies of common diseases or drug sensitivities.
